Haemonetics Operating Expenses 2010-2024 | HAE

Haemonetics operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Haemonetics Annual Operating Expenses
(Millions of US $)
2024 $1,144
2023 $1,013
2022 $912
2021 $781
2020 $885
2019 $884
2018 $848
2017 $905
2016 $953
2015 $870
2014 $892
2013 $836
2012 $639
2011 $566
2010 $562
2009 $512
Haemonetics Quarterly Operating Expenses
(Millions of US $)
2024-12-31 $290
2024-09-30 $294
2024-06-30 $296
2024-03-31 $313
2023-12-31 $290
2023-09-30 $283
2023-06-30 $258
2023-03-31 $269
2022-12-31 $262
2022-09-30 $251
2022-06-30 $231
2022-03-31 $246
2021-12-31 $224
2021-09-30 $215
2021-06-30 $227
2021-03-31 $246
2020-12-31 $200
2020-09-30 $151
2020-06-30 $184
2020-03-31 $212
2019-12-31 $218
2019-09-30 $203
2019-06-30 $252
2019-03-31 $225
2018-12-31 $219
2018-09-30 $216
2018-06-30 $224
2018-03-31 $219
2017-12-31 $233
2017-09-30 $201
2017-06-30 $194
2017-03-31 $286
2016-12-31 $207
2016-09-30 $195
2016-06-30 $218
2016-03-31 $248
2015-12-31 $295
2015-09-30 $201
2015-06-30 $210
2015-03-31 $215
2014-12-31 $214
2014-09-30 $215
2014-06-30 $226
2014-03-31 $229
2013-12-31 $224
2013-09-30 $212
2013-06-30 $226
2013-03-31 $232
2012-12-31 $232
2012-09-30 $208
2012-06-30 $163
2012-03-31 $166
2011-12-31 $166
2011-09-30 $161
2011-06-30 $147
2011-03-31 $141
2010-12-31 $148
2010-09-30 $138
2010-06-30 $139
2010-03-31 $165
2009-12-31 $139
2009-09-30 $130
2009-06-30 $128
2009-03-31 $134
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.214B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $226.329B 27.30
Boston Scientific (BSX) United States $151.960B 38.05
Stryker (SYK) United States $141.576B 30.43
EssilorLuxottica (ESLOY) France $131.433B 0.00
Medtronic (MDT) Ireland $108.503B 15.84
Lonza Group Ag (LZAGY) Switzerland $51.360B 0.00
Haleon (HLN) United Kingdom $46.382B 26.36
ResMed (RMD) United States $34.859B 26.18
GE HealthCare Technologies (GEHC) United States $31.175B 15.16
Agilent Technologies (A) United States $30.637B 20.24
Terumo (TRUMY) Japan $28.678B 0.00
Koninklijke Philips (PHG) Netherlands $23.527B 16.80
Zimmer Biomet Holdings (ZBH) United States $20.336B 12.85
Insulet (PODD) United States $17.646B 75.46
Baxter (BAX) United States $15.890B 11.43
Smith & Nephew SNATS (SNN) United Kingdom $11.790B 0.00
Sunny Optical Technology (SNPTF) China $7.609B 0.00
Demant (WILYY) Denmark $7.600B 0.00
Lantheus Holdings (LNTH) United States $7.119B 17.50
Bio-Rad Laboratories (BIO) United States $6.788B 23.50
Prestige Consumer Healthcare (PBH) United States $4.059B 19.37
Perrigo (PRGO) Ireland $3.496B 10.01
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.378B 28.78
Envista Holdings (NVST) United States $2.745B 22.19
GN Store Nord (GNNDY) Denmark $2.260B 15.23
LeMaitre Vascular (LMAT) United States $2.092B 47.73
QuidelOrtho (QDEL) United States $1.928B 16.15
AtriCure (ATRC) United States $1.715B 0.00
Kestra Medical Technologies (KMTS) United States $1.258B 0.00
Green Thumb Industries (GTBIF) United States $1.250B 19.63
BioLife Solutions (BLFS) United States $1.174B 0.00
AdaptHealth (AHCO) United States $1.129B 10.87
Neogen (NEOG) United States $1.092B 13.97
InMode (INMD) Israel $1.003B 9.18
Phibro Animal Health (PAHC) United States $0.765B 11.73
Evolus (EOLS) United States $0.746B 0.00
Curaleaf Holdings (CURLF) Canada $0.596B 0.00
CeriBell (CBLL) United States $0.587B 0.00
Capricor Therapeutics (CAPR) United States $0.574B 0.00
Owens & Minor (OMI) United States $0.541B 4.61
Valneva SE (VALN) France $0.539B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.493B 0.00
Surmodics (SRDX) United States $0.442B 0.00
Omeros (OMER) United States $0.419B 0.00
Cresco Labs (CRLBF) United States $0.414B 0.00
SNDL (SNDL) Canada $0.389B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.357B 0.00
VAREX IMAGING (VREX) United States $0.346B 15.02
Verano Holdings (VRNOF) United States $0.307B 0.00
Sanara MedTech (SMTI) United States $0.286B 0.00
Viemed Healthcare (VMD) United States $0.275B 24.82
ZimVie (ZIMV) United States $0.264B 15.78
Aurora Cannabis (ACB) Canada $0.261B 46.40
Cerus (CERS) United States $0.260B 0.00
Canopy Growth (CGC) Canada $0.256B 0.00
OraSure Technologies (OSUR) United States $0.237B 0.00
Quanterix (QTRX) United States $0.235B 0.00
Sanuwave Health (SNWV) United States $0.220B 0.00
High Tide (HITI) Canada $0.196B 0.00
Biote (BTMD) United States $0.194B 4.43
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Utah Medical Products (UTMD) United States $0.172B 13.89
Brainsway (BWAY) Israel $0.168B 52.29
Organigram Global (OGI) Canada $0.144B 0.00
FitLife Brands (FTLF) United States $0.143B 17.99
Jin Medical (ZJYL) China $0.140B 0.00
Exagen (XGN) United States $0.123B 0.00
Agape ATP (ATPC) $0.121B 0.00
TerrAscend (TSNDF) Canada $0.108B 0.00
MacroGenics (MGNX) United States $0.101B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Veru (VERU) United States $0.081B 0.00
Fonar (FONR) United States $0.078B 10.86
Cytosorbents (CTSO) United States $0.070B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Zynex (ZYXI) United States $0.067B 0.00
United Health Products (UEEC) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.038B 55.00
Safety Shot (SHOT) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 11.11
Apyx Medical (APYX) United States $0.036B 0.00
Nephros (NEPH) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00